APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iopromide API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Iopromide API Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchIopromide API Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Iopromide API Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Iopromide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iopromide API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Iopromide API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Iopromide API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iopromide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iopromide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iopromide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iopromide API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iopromide API market include Bayer, Stellite and Haichang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iopromide API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iopromide API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iopromide API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iopromide API market size, projected growth trends, production technologies, key applications, and end-use industries.

Iopromide API Segment by Company

Bayer

Stellite

Haichang Pharmaceutical

Iopromide API Segment by Type

Original Drug

Generic Drug

Iopromide API Segment by Application

Hospitals

Clinics

Iopromide API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Iopromide API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iopromide API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iopromide API significant trends, drivers, influence factors in global and regions.

6. To analyze Iopromide API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iopromide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iopromide API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iopromide API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iopromide API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iopromide API industry.

Chapter 3: Detailed analysis of Iopromide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iopromide API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iopromide API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iopromide API Industry Trends Table 2. Iopromide API Industry Drivers Table 3. Iopromide API Industry Opportunities and Challenges Table 4. Iopromide API Industry Restraints Table 5. Global Iopromide API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iopromide API Revenue Share by Company (2021-2026) Table 7. Global Iopromide API Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Iopromide API Sales Volume Share by Company (2021-2026) Table 9. Global Iopromide API Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Iopromide API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iopromide API Key Company Manufacturing Base & Headquarters Table 12. Global Iopromide API Company, Product Type & Application Table 13. Global Iopromide API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iopromide API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Iopromide API Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Iopromide API Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Iopromide API Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Iopromide API Sales Volume Share by Type (2021-2026) Table 23. Global Iopromide API Sales Volume Share by Type (2027-2032) Table 24. Global Iopromide API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Iopromide API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Iopromide API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Iopromide API Sales Value Share by Type (2021-2026) Table 28. Global Iopromide API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Global Iopromide API Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Iopromide API Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Iopromide API Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Iopromide API Sales Volume Share by Application (2021-2026) Table 35. Global Iopromide API Sales Volume Share by Application (2027-2032) Table 36. Global Iopromide API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Iopromide API Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Iopromide API Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Iopromide API Sales Value Share by Application (2021-2026) Table 40. Global Iopromide API Sales Value Share by Application (2027-2032) Table 41. Global Iopromide API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Iopromide API Sales by Region (2021-2026) & (K Units) Table 43. Global Iopromide API Sales Market Share by Region (2021-2026) Table 44. Global Iopromide API Sales by Region (2027-2032) & (K Units) Table 45. Global Iopromide API Sales Market Share by Region (2027-2032) Table 46. Global Iopromide API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Iopromide API Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Iopromide API Sales Value Share by Region (2021-2026) Table 49. Global Iopromide API Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Iopromide API Sales Value Share by Region (2027-2032) Table 51. Global Iopromide API Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Iopromide API Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Iopromide API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Iopromide API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Iopromide API Sales by Country (2021-2026) & (K Units) Table 56. Global Iopromide API Sales Market Share by Country (2021-2026) Table 57. Global Iopromide API Sales by Country (2027-2032) & (K Units) Table 58. Global Iopromide API Sales Market Share by Country (2027-2032) Table 59. Global Iopromide API Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Iopromide API Sales Value Market Share by Country (2021-2026) Table 61. Global Iopromide API Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Iopromide API Sales Value Market Share by Country (2027-2032) Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Iopromide API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bayer Iopromide API Product Portfolio Table 67. Bayer Recent Development Table 68. Stellite Company Information Table 69. Stellite Business Overview Table 70. Stellite Iopromide API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Stellite Iopromide API Product Portfolio Table 72. Stellite Recent Development Table 73. Haichang Pharmaceutical Company Information Table 74. Haichang Pharmaceutical Business Overview Table 75. Haichang Pharmaceutical Iopromide API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Haichang Pharmaceutical Iopromide API Product Portfolio Table 77. Haichang Pharmaceutical Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Iopromide API Distributors List Table 81. Iopromide API Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Iopromide API Product Image Figure 2. Global Iopromide API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iopromide API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iopromide API Sales (2021-2032) & (K Units) Figure 5. Global Iopromide API Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Iopromide API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Iopromide API Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Iopromide API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Iopromide API Sales Volume Share by Type (2021-2032) Figure 14. Global Iopromide API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Iopromide API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Iopromide API Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Global Iopromide API Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Iopromide API Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Iopromide API Sales Volume Share by Application (2021-2032) Figure 22. Global Iopromide API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Iopromide API Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Iopromide API Sales Value Share by Application (2021-2032) Figure 25. Global Iopromide API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Iopromide API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Iopromide API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Iopromide API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Iopromide API Sales Value (2021-2032) & (US$ Million) Figure 30. North America Iopromide API Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Iopromide API Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Iopromide API Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Iopromide API Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Iopromide API Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Iopromide API Sales Value (2021-2032) & (US$ Million) Figure 36. South America Iopromide API Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Iopromide API Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Iopromide API Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Iopromide API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Iopromide API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Iopromide API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iopromide API Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Iopromide API Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospitals
  • Clinics
Companies covered
  • Bayer
  • Stellite
  • Haichang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iopromide API Sales Value (2021-2032)
  4. 1.2.2 Global Iopromide API Sales Volume (2021-2032)
  5. 1.2.3 Global Iopromide API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iopromide API Market Dynamics
  1. 2.1 Iopromide API Industry Trends
  2. 2.2 Iopromide API Industry Drivers
  3. 2.3 Iopromide API Industry Opportunities and Challenges
  4. 2.4 Iopromide API Industry Restraints
3 Iopromide API Market by Company
  1. 3.1 Global Iopromide API Company Revenue Ranking in 2025
  2. 3.2 Global Iopromide API Revenue by Company (2021-2026)
  3. 3.3 Global Iopromide API Sales Volume by Company (2021-2026)
  4. 3.4 Global Iopromide API Average Price by Company (2021-2026)
  5. 3.5 Global Iopromide API Company Ranking (2024-2026)
  6. 3.6 Global Iopromide API Company Manufacturing Base and Headquarters
  7. 3.7 Global Iopromide API Company Product Type and Application
  8. 3.8 Global Iopromide API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iopromide API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iopromide API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iopromide API Market by Type
  1. 4.1 Iopromide API Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Iopromide API Sales Volume by Type
  5. 4.2.1 Global Iopromide API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Iopromide API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Iopromide API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Iopromide API Sales Value by Type
  9. 4.3.1 Global Iopromide API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Iopromide API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Iopromide API Sales Value Share by Type (2021-2032)
5 Iopromide API Market by Application
  1. 5.1 Iopromide API Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Iopromide API Sales Volume by Application
  5. 5.2.1 Global Iopromide API Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Iopromide API Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Iopromide API Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Iopromide API Sales Value by Application
  9. 5.3.1 Global Iopromide API Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Iopromide API Sales Value by Application (2021-2032)
  11. 5.3.3 Global Iopromide API Sales Value Share by Application (2021-2032)
6 Iopromide API Regional Sales and Value Analysis
  1. 6.1 Global Iopromide API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iopromide API Sales by Region (2021-2032)
  3. 6.2.1 Global Iopromide API Sales by Region: 2021-2026
  4. 6.2.2 Global Iopromide API Sales by Region (2027-2032)
  5. 6.3 Global Iopromide API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iopromide API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iopromide API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iopromide API Sales Value by Region (2027-2032)
  9. 6.5 Global Iopromide API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iopromide API Sales Value (2021-2032)
  12. 6.6.2 North America Iopromide API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iopromide API Sales Value (2021-2032)
  15. 6.7.2 Europe Iopromide API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iopromide API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iopromide API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iopromide API Sales Value (2021-2032)
  21. 6.9.2 South America Iopromide API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iopromide API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iopromide API Sales Value Share by Country, 2025 VS 2032
7 Iopromide API Country-level Sales and Value Analysis
  1. 7.1 Global Iopromide API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iopromide API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iopromide API Sales by Country (2021-2032)
  4. 7.3.1 Global Iopromide API Sales by Country (2021-2026)
  5. 7.3.2 Global Iopromide API Sales by Country (2027-2032)
  6. 7.4 Global Iopromide API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iopromide API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iopromide API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iopromide API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iopromide API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iopromide API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iopromide API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iopromide API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iopromide API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iopromide API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iopromide API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iopromide API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iopromide API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iopromide API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iopromide API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iopromide API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iopromide API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iopromide API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iopromide API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iopromide API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iopromide API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iopromide API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iopromide API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iopromide API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iopromide API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iopromide API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iopromide API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iopromide API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iopromide API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iopromide API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iopromide API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iopromide API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iopromide API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iopromide API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iopromide API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iopromide API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iopromide API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iopromide API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iopromide API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iopromide API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iopromide API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iopromide API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iopromide API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iopromide API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iopromide API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iopromide API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iopromide API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iopromide API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iopromide API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iopromide API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iopromide API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iopromide API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iopromide API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iopromide API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iopromide API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iopromide API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iopromide API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iopromide API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iopromide API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iopromide API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iopromide API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iopromide API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iopromide API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iopromide API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iopromide API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iopromide API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iopromide API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iopromide API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iopromide API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iopromide API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iopromide API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iopromide API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iopromide API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iopromide API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iopromide API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iopromide API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iopromide API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iopromide API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iopromide API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iopromide API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iopromide API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iopromide API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iopromide API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iopromide API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iopromide API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iopromide API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iopromide API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Iopromide API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Iopromide API Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Stellite
  8. 8.2.1 Stellite Company Information
  9. 8.2.2 Stellite Business Overview
  10. 8.2.3 Stellite Iopromide API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Stellite Iopromide API Product Portfolio
  12. 8.2.5 Stellite Recent Developments
  13. 8.3 Haichang Pharmaceutical
  14. 8.3.1 Haichang Pharmaceutical Company Information
  15. 8.3.2 Haichang Pharmaceutical Business Overview
  16. 8.3.3 Haichang Pharmaceutical Iopromide API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Haichang Pharmaceutical Iopromide API Product Portfolio
  18. 8.3.5 Haichang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iopromide API Value Chain Analysis
  2. 9.1.1 Iopromide API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iopromide API Sales Mode & Process
  6. 9.2 Iopromide API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iopromide API Distributors
  9. 9.2.3 Iopromide API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst